Healthcare Industry Reports

Reports > Healthcare > Selected Report

Global Intravenous Immunoglobulin (IVIg) Market Report for Period 2018 till 2026

Single User: $2999
Multiple User: $3999
Enterprise User: $4999


Report Summary:

Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or lot of Intravenous Immunoglobulin.


Scope of the Report:
This report focuses on the Intravenous Immunoglobulin (IVIg) in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Baxter
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
IVIg Liquid
IVIg Powder

Market Segment by Applications, can be divided into
Immunodeficiency
Autoimmune Disease
Acute Infection

There are 15 Chapters to deeply display the global Intravenous Immunoglobulin (IVIg) market.

Chapter 1, to describe Intravenous Immunoglobulin (IVIg) Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Intravenous Immunoglobulin (IVIg), with sales, revenue, and price of Intravenous Immunoglobulin (IVIg), in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Intravenous Immunoglobulin (IVIg), for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Intravenous Immunoglobulin (IVIg) market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Intravenous Immunoglobulin (IVIg) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents / Index:

Table of Contents
1 Market Overview
1.1 Intravenous Immunoglobulin (IVIg) Introduction
1.2 Market Analysis by Type
1.2.1 IVIg Liquid
1.2.2 IVIg Powder
1.3 Market Analysis by Applications
1.3.1 Immunodeficiency
1.3.2 Autoimmune Disease
1.3.3 Acute Infection
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Baxter
2.1.1 Business Overview
2.1.2 Intravenous Immunoglobulin (IVIg) Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Baxter Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Grifols
2.2.1 Business Overview
2.2.2 Intravenous Immunoglobulin (IVIg) Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 CSL
2.3.1 Business Overview
2.3.2 Intravenous Immunoglobulin (IVIg) Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 CSL Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Octapharma
2.4.1 Business Overview
2.4.2 Intravenous Immunoglobulin (IVIg) Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Biotest
2.5.1 Business Overview
2.5.2 Intravenous Immunoglobulin (IVIg) Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Kedrion
2.6.1 Business Overview
2.6.2 Intravenous Immunoglobulin (IVIg) Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Hualan Bio
2.7.1 Business Overview
2.7.2 Intravenous Immunoglobulin (IVIg) Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 CNBG
2.8.1 Business Overview
2.8.2 Intravenous Immunoglobulin (IVIg) Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 CNBG Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Shanghai RAAS
2.9.1 Business Overview
2.9.2 Intravenous Immunoglobulin (IVIg) Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 CBPO
2.10.1 Business Overview
2.10.2 Intravenous Immunoglobulin (IVIg) Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 CBPO Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 LFB Group
2.11.1 Business Overview
2.11.2 Intravenous Immunoglobulin (IVIg) Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 BPL
2.12.1 Business Overview
2.12.2 Intravenous Immunoglobulin (IVIg) Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 BPL Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Sichuan Yuanda Shuyang
2.13.1 Business Overview
2.13.2 Intravenous Immunoglobulin (IVIg) Type and Applications
2.13.2.1 Type 1
2.13.2.2 Type 2
2.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Intravenous Immunoglobulin (IVIg) Market Competition, by Manufacturer
3.1 Global Intravenous Immunoglobulin (IVIg) Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Intravenous Immunoglobulin (IVIg) Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Intravenous Immunoglobulin (IVIg) Manufacturer Market Share in 2017
3.4.2 Top 5 Intravenous Immunoglobulin (IVIg) Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Intravenous Immunoglobulin (IVIg) Market Analysis by Regions
4.1 Global Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Regions
4.1.1 Global Intravenous Immunoglobulin (IVIg) Sales by Regions (2013-2018)
4.1.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Regions (2013-2018)
4.2 North America Intravenous Immunoglobulin (IVIg) Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Intravenous Immunoglobulin (IVIg) Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Intravenous Immunoglobulin (IVIg) Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales, Revenue and Growth Rate (2013-2018)
5 North America Intravenous Immunoglobulin (IVIg) by Countries, Type, Application and Manufacturers
5.1 North America Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Countries
5.1.1 North America Intravenous Immunoglobulin (IVIg) Sales by Countries (2013-2018)
5.1.2 North America Intravenous Immunoglobulin (IVIg) Revenue by Countries (2013-2018)
5.1.3 United States Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
5.1.4 Canada Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
5.1.5 Mexico Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
5.2 North America Intravenous Immunoglobulin (IVIg) Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Intravenous Immunoglobulin (IVIg) Sales by Manufacturers (2016-2017)
5.2.2 North America Intravenous Immunoglobulin (IVIg) Revenue by Manufacturers (2016-2017)
5.3 North America Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Intravenous Immunoglobulin (IVIg) Sales and Sales Share by Type (2013-2018)
5.3.2 North America Intravenous Immunoglobulin (IVIg) Revenue and Revenue Share by Type (2013-2018)
5.4 North America Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Intravenous Immunoglobulin (IVIg) Sales and Sales Share by Application (2013-2018)
5.4.2 North America Intravenous Immunoglobulin (IVIg) Revenue and Revenue Share by Application (2013-2018)
6 Europe Intravenous Immunoglobulin (IVIg) by Countries, Type, Application and Manufacturers
6.1 Europe Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Countries
6.1.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Countries (2013-2018)
6.1.2 Europe Intravenous Immunoglobulin (IVIg) Revenue by Countries (2013-2018)
6.1.3 Germany Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
6.1.4 UK Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
6.1.5 France Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
6.1.6 Russia Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
6.1.7 Italy Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
6.2 Europe Intravenous Immunoglobulin (IVIg) Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Manufacturers (2016-2017)
6.2.2 Europe Intravenous Immunoglobulin (IVIg) Revenue by Manufacturers (2016-2017)
6.3 Europe Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Intravenous Immunoglobulin (IVIg) Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Intravenous Immunoglobulin (IVIg) Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Intravenous Immunoglobulin (IVIg) Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Intravenous Immunoglobulin (IVIg) Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Intravenous Immunoglobulin (IVIg) by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue by Countries (2013-2018)
7.1.3 China Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
7.1.4 Japan Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
7.1.5 Korea Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
7.1.6 India Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue and Revenue Share by Application (2013-2018)
8 South America Intravenous Immunoglobulin (IVIg) by Countries, Type, Application and Manufacturers
8.1 South America Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Countries
8.1.1 South America Intravenous Immunoglobulin (IVIg) Sales by Countries (2013-2018)
8.1.2 South America Intravenous Immunoglobulin (IVIg) Revenue by Countries (2013-2018)
8.1.3 Brazil Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
8.1.4 Argentina Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
8.1.5 Colombia Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
8.2 South America Intravenous Immunoglobulin (IVIg) Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Intravenous Immunoglobulin (IVIg) Sales by Manufacturers (2016-2017)
8.2.2 South America Intravenous Immunoglobulin (IVIg) Revenue by Manufacturers (2016-2017)
8.3 South America Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Intravenous Immunoglobulin (IVIg) Sales and Sales Share by Type (2013-2018)
8.3.2 South America Intravenous Immunoglobulin (IVIg) Revenue and Revenue Share by Type (2013-2018)
8.4 South America Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Intravenous Immunoglobulin (IVIg) Sales and Sales Share by Application (2013-2018)
8.4.2 South America Intravenous Immunoglobulin (IVIg) Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Intravenous Immunoglobulin (IVIg) by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
9.1.4 UAE Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
9.1.5 Egypt Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
9.1.7 South Africa Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue and Revenue Share by Application (2013-2018)
10 Global Intravenous Immunoglobulin (IVIg) Market Segment by Type
10.1 Global Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Intravenous Immunoglobulin (IVIg) Sales and Market Share by Type (2013-2018)
10.1.2 Global Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Type (2013-2018)
10.2 IVIg Liquid Sales Growth and Price
10.2.1 Global IVIg Liquid Sales Growth (2013-2018)
10.2.2 Global IVIg Liquid Price (2013-2018)
10.3 IVIg Powder Sales Growth and Price
10.3.1 Global IVIg Powder Sales Growth (2013-2018)
10.3.2 Global IVIg Powder Price (2013-2018)
11 Global Intravenous Immunoglobulin (IVIg) Market Segment by Application
11.1 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2013-2018)
11.2 Immunodeficiency Sales Growth (2013-2018)
11.3 Autoimmune Disease Sales Growth (2013-2018)
11.4 Acute Infection Sales Growth (2013-2018)
12 Intravenous Immunoglobulin (IVIg) Market Forecast (2018-2023)
12.1 Global Intravenous Immunoglobulin (IVIg) Sales, Revenue and Growth Rate (2018-2023)
12.2 Intravenous Immunoglobulin (IVIg) Market Forecast by Regions (2018-2023)
12.2.1 North America Intravenous Immunoglobulin (IVIg) Market Forecast (2018-2023)
12.2.2 Europe Intravenous Immunoglobulin (IVIg) Market Forecast (2018-2023)
12.2.3 Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Forecast (2018-2023)
12.2.4 South America Intravenous Immunoglobulin (IVIg) Market Forecast (2018-2023)
12.2.5 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Forecast (2018-2023)
12.3 Intravenous Immunoglobulin (IVIg) Market Forecast by Type (2018-2023)
12.3.1 Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Type (2018-2023)
12.3.2 Global Intravenous Immunoglobulin (IVIg) Market Share Forecast by Type (2018-2023)
12.4 Intravenous Immunoglobulin (IVIg) Market Forecast by Application (2018-2023)
12.4.1 Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Application (2018-2023)
12.4.2 Global Intravenous Immunoglobulin (IVIg) Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

Research Methodology

The market research report added recently to collection of Market Reports Company is based on detailed qualitative and quantitative analysis. The research report is a blend of both bottom up and top down research with the help of which quantitative aspects of the market are determined. Besides this various statistical models, projection techniques and sampling techniques are implemented for quantitative analysis.
The qualitative analysis includes through interactive study with all major industry participants across the industrial value chain. The analysis includes extensive interviews with raw material suppliers, experienced front line staff, directors, CEOs, distributors, major manufacturers, industry experts and end-users. Interaction are usually done with the help of primary interviews, surveys, and vendor briefings. All major factors that influence this market are studied in this research report. The market size for top level markets and sub-segments is normalized, and the impact of various macro and micro economic factors are analyzed during market forecast.

Secondary Research
Secondary sources play a vital role in collection of raw data. Various paid and open access data sources are referred for collection for secondary data. Some of the major secondary data sources referred include:

■ Press releases, annual reports, Non-Profit organizations
■ Industry associations, governmental agencies and customs data
■ Directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), etc.

Primary Research
In Primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Some of the major primary sources include:

■ Product manufacturers
■ Opinion leaders, industry experts and research institutions
■ Distributors, Dealer and Traders
■ Raw Materials suppliers and producers etc.

The data collected through secondary research is validated with the help of primary research respondents.

Data Models
Wherever no credible data sources are available, various data models are implemented which help to develop wide data sets.

Request a Sample of this Report

Please fill out the details requested below.
Our representative will contact you within 1 hour.


Name:


Email ID:


Name of Company:


Designation/Role:


Country:


Message:


Please Enter Captcha Below:

Report Details:



Report ID: 39942

Category: 11

Published date: 2018-05-23 07:41:52

Number of Pages: 107

Publisher Name: GIR

Over all Rating: 99 % (Average of Ratings provided by clients)